93565-13-0

Upstream product

• 124-63-0 methanesulfonyl chloride 
• 93565-15-2 4-methoxy-N-methyl-3-nitrobenzeneacetamide 
• 10463-21-5 3-nitro-4-hydroxyphenylacetyl chloride 
• 70382-04-6 4-hydroxy-N-methyl-3-nitrobenzeneacetamide 
• 10463-20-4 4-hydroxy-3-nitrophenylacetic acid 
• 93565-16-3 4-methoxy-N-methyl-3-aminobenzeneacetamide 

Downstream Products

• 93565-17-4 N-<2-methoxy-5-<2-(methylamino)ethyl>phenyl>methanesulfonamide 
• 93565-14-1 SKF 102652 

Relevant academic research and scientific papers

USE OF ALPHA1A-SELECTIVE ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF URINARY INCONTINENCE

The present invention provides a method of treating urinary incontinence in a subject which comprises administering to the subject a therapeutically effective amount of a compound having the following structure: STR1 wherein each of the substiutents for the compound is as defined in the specification.

N-phenyl>methanesulfonamide. A Potent Agonist Which Releases Intracellular Calcium by Activation of α1-Adrenoceptors

N-phenyl>methanesulfonamide (SKandF 102652) has been prepared and characterized pharmacologically.It is a potent agonist with an EC50 of 25 nM at α1-adrenoceptors as determined in the isolated perfused rabbit